Oct. 22, 2024
Sponsored by MEDSIR
MEDSIR (Medica Scientia Innovation Research) is an international company, based in Barcelona and New Jersey, specializing in the design and …
April 18, 2024
Sponsored by Trialize
In an industry as critical as clinical trials, where efficient data management and swift processes are paramount, outdated tech methods …
April 8, 2024
Sponsored by Intelligencia AI
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often …
April 1, 2024
Sponsored by Trialize
In the realm of clinical trials, efficient data management and monitoring are crucial yet often hampered by outdated and time-consuming …
The field of AI ligand pose prediction in the protein binding pockets (aka “AI docking”) witnessed unprecedented development in the …
We at Receptor.AI are excited to present the next important milestone in the development of our next-generation AI docking model, …
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Jan. 17, 2023
Sponsored by Syntekabio
Before the age of modern drug discovery, the pharmaceutical industry had been plagued with uncertainty and processing challenges, including the …
Introduction Glioblastomas (GBM) are devastating brain tumors and rank as one of the most aggressive human cancers with a median …
Oct. 7, 2022
Sponsored by Arctoris
Arctoris is driven by a relentless pursuit to make drug discovery better. An industry where bringing a single drug to …
There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both …
A key step in the targeted protein degradation (TPD) process is the formation of an induced proximity complex, where a …
